RGT argent biopharma limited

Ann: CannEpil Receives Approval for Prescription in Germany, page-7

  1. 249 Posts.
    lightbulb Created with Sketch. 58
    They haven't ever shown that they can make any money out of the special access scheme, losing over $70m of shareholders funds.. It's a consistent burn on the bottom line. So why are they continuing to promote special access as a priority strategy? It's not only delusional, but borderline negligent. It's starting to get scary how ignorant this group are..
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
7.3¢
Change
-0.003(3.95%)
Mkt cap ! $5.269M
Open High Low Value Volume
7.5¢ 8.0¢ 7.3¢ $9.291K 123K

Buyers (Bids)

No. Vol. Price($)
4 63321 7.3¢
 

Sellers (Offers)

Price($) Vol. No.
7.9¢ 57629 1
View Market Depth
Last trade - 14.46pm 07/08/2025 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.